Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

(2020) Marissa B. Serafin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Natural products may interfere with SARS-CoV-2 attachment to the host cell

(2020) Abdo A. Elfiky   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

COVID-19 spike-host cell receptor GRP78 binding site prediction

(2020) Ibrahim M. Ibrahim et al.   JOURNAL OF INFECTION

Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atoms Simulations

(2020) Angelo Spinello et al.   Journal of Physical Chemistry Letters

Structural basis of receptor recognition by SARS-CoV-2

(2020) Jian Shang et al.   NATURE

Rapid repurposing of drugs for COVID-19

(2020) R. Kiplin Guy et al.   SCIENCE

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

(2020) Xiuyuan Ou et al.   Nature Communications

Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)

(2020) Muhammad Shahid Nadeem et al.   Pathogens

Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

(2020) Mandeep R Mehra et al.   LANCET

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

(2020) Muhammad Adnan Shereen et al.   Journal of Advanced Research

Neratinib in HER2-Positive Breast Cancer Patients

(2019) Rutugandha Paranjpe et al.   ANNALS OF PHARMACOTHERAPY

Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies

(2019) Fiona H Tan et al.   OncoTargets and Therapy

Coronavirus envelope protein: current knowledge

(2019) Dewald Schoeman et al.   Virology Journal

GRP78: A cell's response to stress

(2019) Ibrahim M. Ibrahim et al.   LIFE SCIENCES

Systemic release of heat-shock protein 27 and 70 following severe trauma

(2019) Thomas Haider et al.   Scientific Reports

Unfolded Protein Response in Acute Respiratory Distress Syndrome

(2019) Nektarios Barabutis   LUNG

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario

(2019) Josefa Girona et al.   Journal of Clinical Medicine

Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models

(2019) Simon P. Langdon et al.   Scientific Reports

Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report

(2019) Le-Tian Huang et al.   Frontiers in Oncology

Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular dynamics studies

(2018) K. R. D. Sagara N. S. Gurusinghe et al.   Scientific Reports

GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry and Replication in Mammalian Cells

(2017) Minu Nain et al.   JOURNAL OF VIROLOGY

DrugBank 5.0: a major update to the DrugBank database for 2018

(2017) David S Wishart et al.   NUCLEIC ACIDS RESEARCH

Targeting HSP70 and GRP78 in canine osteosarcoma cells in combination with doxorubicin chemotherapy

(2016) Jonathan Asling et al.   CELL STRESS & CHAPERONES

Probing the ATP Site of GRP78 with Nucleotide Triphosphate Analogs

(2016) Scott J. Hughes et al.   PLoS One

Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells

(2015) Caroline V.M. Verhagen et al.   RADIOTHERAPY AND ONCOLOGY

Close and Allosteric Opening of the Polypeptide-Binding Site in a Human Hsp70 Chaperone BiP

(2015) Jiao Yang et al.   STRUCTURE

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

(2014) Julie Dyall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

HSPA5 is an essential host factor for Ebola virus infection

(2014) St. Patrick Reid et al.   ANTIVIRAL RESEARCH

Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling

(2014) Neng Wang et al.   CARCINOGENESIS

GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids

(2014) Anna A. Birukova et al.   MOLECULAR BIOLOGY OF THE CELL

HKH40A downregulates GRP78/BiP expression in cancer cells

(2014) T Kosakowska-Cholody et al.   Cell Death & Disease

Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78

(2013) S Martin et al.   BRITISH JOURNAL OF CANCER

Danusertib, an aurora kinase inhibitor

(2012) Hielke J Meulenbeld et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity

(2011) Alba T. Macias et al.   JOURNAL OF MEDICINAL CHEMISTRY

Japanese encephalitis virus co-opts the ER-stress response protein GRP78 for viral infectivity

(2011) Yi-Ping Wu et al.   Virology Journal

Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP

(2010) Yi Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus

(2008) Rupert Langer et al.   BMC CANCER

Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery

(2008) Santiago Vilar et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS